Introducing Botox in a bottle! I was sceptical when I heard about this £10 serum that everyone seems to be obsessed with - until I tried it myself. The results were stunning: BETHAN KING
I've dabbled with wrinkle-relaxing jabs to (temporarily) disappear the vertical frown lines between my eyebrows and the horizontal ones along my forehead for a couple of years.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
9 minutes ago
- Daily Mail
Simon Cowell's pal Lucy Spraggan reveals he also considered signing up for SAS: Who Dares Wins but she had to warn him off tough series due to health concerns
Simon Cowell 's close pal Lucy Spraggan says the music mogul considered signing up for Channel 4 's SAS: Who Dares Wins - but she told him he has 'no chance'. The former X Factor frontman may live a life of luxury, but it seems he wanted to show just how tough he is. Simon, 65, was pleased to hear that Lucy had been in talks for the series, where it puts celebs through their paces as they take on different intense challenges. Lucy - who has grown close to Simon since starring on The X Factor in 2012 - said how the entertainment mogul thought it would be a 'great idea' for her to do the show as she loves being outdoors and they often enjoy shooting air rifles together. And he was so thrilled for her that he reportedly said he'll 'maybe try and have a go at it'. Lucy told The Sun: 'I was like, "You would literally die!" It was funny because it really contextualised how hard it was that I just straight away said to him, "You would have no chance".' The new series of SAS: Who Dares Wins, which begins next Sunday at 9pm, sees Simon give Lucy a pep talk, but it doesn't end well. Her friendship with Simon is better than ever, and last year he even walked her down the aisle during her star-studded wedding to girlfriend Emilia Smith. 'It was really strange,' Lucy laughed. 'It's a high stress environment and I looked to the side and saw him, like this is weird! 'But he was here and Lauren [Silverman] was there.' In recent months, Simon has been working on launching a new talent show. The show titled The Next Act follows Cowell on a mission to find the next global boyband in the vein of One Direction, and is due to stream on Netflix in the coming months. While Netflix is yet to commission the second series, it is thought he is keen to capitalise on the buzz and is already eyeing a second series - this time focusing on up-and-coming girl groups. A source told the publication: 'There's huge amount of excitement around the boyband search show dropping on Netflix, which is expected to drop later this year. 'So it makes sense to consider a sequel with a similar concept but looking for the female equivalent. 'And if anyone can do it, it's Simon. After all, through One Direction and Little Mix, he helped deliver two of the biggest pop acts of the last two decades.' The Next Act is thought to air over six episodes, where viewers will see nationwide open auditions, exclusive behind-the-scenes access and the release of the group's debut single.
Telegraph
11 minutes ago
- Telegraph
The current testing system for prostate cancer is failing too many men
SIR – Congratulations on your campaign (Leading Article, July 26) for a targeted screening programme for prostate cancer. My own diagnosis earlier this year made me realise that a national screening test is urgently needed. I was (and still am) asymptomatic, and have no known family history. I requested a PSA test from my GP following a chance meeting with an acquaintance who had recently been diagnosed with localised advanced prostate cancer – he had originally decided against a test, but was persuaded after learning of Sir Chris Hoy's experience. I am now being treated for localised advanced (high risk) prostate cancer. Your reports of men having to request a PSA test from their GP several times, even with symptoms, are appalling. A friend of a family member had a similar experience. He had experienced typical symptoms and went to see his GP, who gave him various blood and other tests, but notably not a PSA test. Having sought a second opinion privately, he was then diagnosed with prostate cancer, which has spread throughout his body. I know men who have received an unenthusiastic response from their GP; other men are completely ignorant of the cancer and its symptoms. The status quo is a disaster for men. I fully support your campaign and your call for better training and awareness for GPs. Geoff Stevens Harrogate, North Yorkshire SIR – I was repeatedly refused the PSA test by GPs on the grounds that the test was too sensitive and unreliable. I eventually managed to persuade a GP to comply, but only because I refused to be placed on statins, which were to be prescribed for no other reason than my age. The results of the test were elevated but, after treatment, at least I am now one of those who will die with, hopefully not of, prostate cancer. The worst irony of my experience was the revelation, from the nurse specialist who took my family history, that because my mother and maternal grandmother had both died of breast cancer, I was in a higher risk category. Had I known this, I might have convinced previous GPs to test my PSA earlier and maybe even qualified for prostatectomy, like younger friends and relatives with whom I have compared notes, thereby avoiding the unpleasant side effects of radiotherapy. Dermod Malley Halstead, Essex SIR – All men need to be tested for prostate cancer. My husband had no signs or symptoms, but we had lost a friend to the disease, so our enlightened GP ordered a PSA test which indicated that my husband, then 55, had a problem. Our son has been tested since he was 45 years old. My husband and his specialist fought it for 22 years but sadly he lost his battle in 2019. Marilla Blenkin Ashford, Kent
The Guardian
11 minutes ago
- The Guardian
Demand for weight loss drugs is becoming unsustainable, say pharmacists
Demand for weight loss drugs is becoming so 'unsustainable' that demand may soon outstrip supply, pharmacists have warned. The National Pharmacy Association (NPA) said supply problems could encourage people to turn to unregulated online sources, despite the risks involved. The number of people in the UK using drugs such as Wegovy and Mounjaro has soared to well above a million, with most patients paying to get them privately. During April, 1.6m packs of Mounjaro and Wegovy were bought in Britain, with the number thought to correlate closely with the number of people using them. 'Spiralling demand for weight loss medication risks going far beyond what is clinically deliverable', the NPA said. The drugs might need to be reserved for those in greatest need because they are so overweight instead of being given to the 'worried well', it added. New polling has found that 21% of Britons have tried to get hold of the medications over the past year, a figure that rises to 35% among 18- to 34-year-olds. The same survey found that 41% of all age groups would use them if they were free on the NHS. This figure rose to 64% among those aged 25-34. Savanta interviewed a representative sample of 2,002 adults aged 18 or over online from 20-23 June for the NPA, which represents 6,000 independent pharmacies. 'Weight loss jabs are one of the biggest drug innovations this century but growing demand for weight loss treatment highlights the need to make sure this is appropriate for those who want it,' said Olivier Picard, the NPA's chair. 'It's clear from this polling that more people are interested in getting weight loss jabs than can benefit from weight loss medication.' Supply of the medicines has been hit by shortages in some parts of the UK, including for higher doses of Mounjaro, the NPA said. Supply has been restricted to some pharmacies, which has stopped some new patients from going on to the drugs. The Medicines and Healthcare products Regulatory Agency, the UK's drugs watchdog, has warned patients to obtain the drugs only with a doctor's prescription, and not from beauty parlours or websites. A Department of Health spokesperson said more people would be able to obtain 'revolutionary' weight loss jabs over the next few years. 'Weight loss drugs are a powerful tool in tackling the obesity crisis head-on as part of our 10-year health plan', they added. 'This government is committed to ensuring that more people have access to these revolutionary drugs when needed, and crucially that they are able to do so in a safe and controlled way. We will ensure that those most in need will receive treatment first.' About 220,000 people in England are due to be offered tirzepatide, a diabetes drug that promotes weight loss, over the next three years. Pharmacies already provide about 85% of all weight loss drugs and need to be closely involved in the expansion of access, Picard added. 'The government should use the massive untapped expertise and skills of pharmacists to help speed up the NHS's weight loss medication programme to millions of the most in need patients,' he said.
